文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

辅助放化疗治疗乳腺叶状肿瘤患者:系统评价和荟萃分析。

Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis.

机构信息

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang West Road, Guangzhou, 510120, People's Republic of China.

Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang West Road, Guangzhou, 510120, People's Republic of China.

出版信息

BMC Cancer. 2019 Apr 23;19(1):372. doi: 10.1186/s12885-019-5585-5.


DOI:10.1186/s12885-019-5585-5
PMID:31014268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6480723/
Abstract

BACKGROUND: As the efficacy of radiotherapy and chemotherapy for treatment of phyllodes tumors (PTs) remains unclear, this study aimed to review all available data and evaluate the roles of radiotherapy and chemotherapy in PT treatment. METHODS: We performed a comprehensive search of databases, including PubMed, Web of Science and the Cochrane Library. The outcomes of interest included the local recurrence (LR) rate, metastasis rate, disease-free survival rate and overall survival rate. RESULTS: Seventeen studies enrolling 696 patients were included in this random effect meta-analysis. Subgroup analysis and meta-regression were also conducted to determine study heterogeneity. A pooled local recurrence rate of 8% (95% CI: 1-22%) was observed with a statistical heterogeneity of I = 86.6% (p < 0.01) for radiotherapy. This was lower than the recurrence rate of 12% for simple surgical treatment (95% CI: 7-18%). Meta-regression analysis found that surgical margin status was the main source of heterogeneity (p = 0.04). The metastasis rate of 4% (95% CI: 0-11%) for patients receiving radiotherapy without significant heterogeneity was also lower than the rate for the simple surgery group (8, 95% CI: 3-15%). The available data for chemotherapy were too limited to support meta-analysis. Accordingly, we offer a pure review of these data. CONCLUSION: Our findings suggest that radiotherapy is effective in achieving local disease control and preventing metastasis.

摘要

背景:由于放疗和化疗治疗叶状肿瘤(PTs)的疗效仍不清楚,本研究旨在回顾所有可用数据并评估放疗和化疗在 PT 治疗中的作用。

方法:我们对包括 PubMed、Web of Science 和 Cochrane Library 在内的数据库进行了全面搜索。感兴趣的结局包括局部复发(LR)率、转移率、无疾病生存率和总生存率。

结果:这项随机效应荟萃分析纳入了 17 项研究共 696 例患者。还进行了亚组分析和荟萃回归以确定研究异质性。放疗的局部复发率为 8%(95%CI:1-22%),异质性 I = 86.6%(p < 0.01)。这低于单纯手术治疗的 12%(95%CI:7-18%)复发率。荟萃回归分析发现手术切缘状态是异质性的主要来源(p = 0.04)。接受放疗且无明显异质性的患者转移率为 4%(95%CI:0-11%),也低于单纯手术组(8%,95%CI:3-15%)。化疗的可用数据太有限,无法支持荟萃分析。因此,我们对这些数据进行了纯回顾。

结论:我们的研究结果表明,放疗在实现局部疾病控制和预防转移方面是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2cf/6480723/bf27dd78fa6c/12885_2019_5585_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2cf/6480723/a35acdfc4f8e/12885_2019_5585_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2cf/6480723/bf27dd78fa6c/12885_2019_5585_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2cf/6480723/a35acdfc4f8e/12885_2019_5585_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2cf/6480723/bf27dd78fa6c/12885_2019_5585_Fig2_HTML.jpg

相似文献

[1]
Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis.

BMC Cancer. 2019-4-23

[2]
Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.

Cancer Radiother. 2018-4

[3]
Malignant phyllodes tumor of the breast: treatment and prognosis.

Breast J. 2014

[4]
[Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].

Zhonghua Zhong Liu Za Zhi. 2009-1

[5]
Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009.

Ann Surg Oncol. 2014-4

[6]
Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).

Breast Cancer Res Treat. 2018-5-28

[7]
Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.

Jpn J Clin Oncol. 2007-10

[8]
Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence.

Int J Surg. 2022-11

[9]
The Impact of Radiotherapy and Histological Risk Factors on Outcomes in Malignant Phyllodes Tumors.

Clin Breast Cancer. 2020-12

[10]
A retrospective review of phyllodes tumours of the breast: A single institution experience.

Breast. 2017-12-9

引用本文的文献

[1]
Recurrent Malignant Phyllodes Tumor of the Breast: A Case Report.

Clin Case Rep. 2025-9-4

[2]
Contemporary management of phyllodes tumours of the breast: recommendations from the UK Association of Breast Surgery.

Br J Surg. 2025-8-1

[3]
Construction of a clinical prediction model for overall survival and cancer-specific survival in malignant phyllode tumor of the breast based on the SEER database.

Discov Oncol. 2025-7-1

[4]
Full-Thickness Chest Wall Resection and Reconstruction for Locally Invasive Phyllodes Tumors: A Systematic Review.

Cancers (Basel). 2025-6-8

[5]
Ruptured phyllodes tumors of the breast: a comprehensive case series and literature review on clinical challenges.

World J Surg Oncol. 2025-6-20

[6]
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors.

Life (Basel). 2025-4-20

[7]
Prognostic factors and treatment insights for metastatic malignant phyllode tumors.

Breast. 2025-6

[8]
Phyllodes tumors of the breast: A comprehensive review of diagnosis, treatment, and follow-up.

Clinics (Sao Paulo). 2025-3-14

[9]
Malignant transformation of recurrent benign phyllodes tumor: a case report and comprehensive review of literature.

Ann Med Surg (Lond). 2024-11-12

[10]
Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy: A Case Report.

J Breast Cancer. 2024-10

本文引用的文献

[1]
Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis.

Ann Surg Oncol. 2019-1-7

[2]
Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast.

In Vivo. 2019

[3]
Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre.

Breast. 2018-11-26

[4]
Malignant phyllodes tumors of the breast: A single institution experience.

Med J Malaysia. 2018-10

[5]
Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).

Breast Cancer Res Treat. 2018-5-28

[6]
Radiotherapy in Phyllodes Tumour.

J Clin Diagn Res. 2017-1

[7]
Phyllodes tumors of the breast: Analysis of 35 cases from a single institution.

J Egypt Natl Canc Inst. 2016-12

[8]
Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.

Jpn J Clin Oncol. 2014-11-11

[9]
Malignant phyllodes tumor of the breast: treatment and prognosis.

Breast J. 2014

[10]
Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.

Ann Surg Oncol. 2014-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索